Allergan Inc
AGN
AGN was delisted on the 16th of March, 2015.
819 hedge funds and large institutions have $63B invested in Allergan Inc in 2014 Q4 according to their latest regulatory filings, with 150 funds opening new positions, 233 increasing their positions, 328 reducing their positions, and 70 closing their positions.
114% more first-time investments, than exits
New positions opened: 150 | Existing positions closed: 70
63% more funds holding in top 10
Funds holding in top 10: 64 → 104 (+40)
29% more capital invested
Capital invested by funds: $48.9B → $63B (+$14.2B)
9% more funds holding
Funds holding: 749 → 819 (+70)
29% less repeat investments, than reductions
Existing positions increased: 233 | Existing positions reduced: 328
42% less call options, than puts
Call options by funds: $1.34B | Put options by funds: $2.32B
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DKCM
Davidson Kempner Capital Management
New York
|
+$434M |
| 2 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$386M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$279M |
| 4 |
ACPU
Arrowgrass Capital Partners (US)
Dover,
Delaware
|
+$257M |
| 5 |
FTCM
Fir Tree Capital Management
New York
|
+$241M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jennison Associates
New York
|
-$573M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$493M |
| 3 |
PSCM
Pershing Square Capital Management
New York
|
-$446M |
| 4 |
HL
Harding Loevner
Bridgewater,
New Jersey
|
-$303M |
| 5 |
O
OppenheimerFunds
New York
|
-$289M |
AGN Hedge Fund Activity: Q4 2014 in Review
819 of the 3,751 institutional investors tracked by Wall St. Rank reported a position in Allergan Inc (AGN) for Q4 2014, worth a combined $63B — up 29% from $48.9B a quarter earlier.
Buyers outnumbered sellers: 150 funds opened new AGN positions and 70 closed out — a net gain of 80 holders — while 233 added to existing stakes and 328 trimmed.
The largest buyer was Davidson Kempner Capital Management, adding an estimated $434M. The largest seller was Jennison Associates, cutting an estimated $573M.
- 819 institutional investors held Allergan Inc (AGN) as of Q4 2014, up from 749 in Q3 2014.
- Funds reported $63B of Allergan Inc stock for Q4 2014, up 29% quarter-over-quarter.
- 150 funds opened new Allergan Inc positions in Q4 2014 and 70 closed out, a net change of +80 holders.
- The largest Allergan Inc buyer in Q4 2014 was Davidson Kempner Capital Management, an estimated $434M added.
- The largest Allergan Inc seller in Q4 2014 was Jennison Associates, an estimated $573M sold.
Based on aggregated 13F filings for Q4 2014.